Comparison between clinical and metabolic characteristics of type 1 diabetic patients positive (anti-CD38+) and negative (anti-CD38−) for anti-CD38 autoantibodies
| . | anti-CD38+ . | anti-CD38− . |
|---|---|---|
| n | 18 | 76 |
| Sex (%) | ||
| Male | 47.1 | 56.2 |
| Female | 52.9 | 43.8 |
| Age (years) | 36.8 ± 13.9 | 37.3 ± 11.2 |
| BMI (kg/m2) | 23.5 ± 3.4 | 24.4 ± 3.3 |
| Diabetes duration (years) | 19.9 ± 10.9 | 20.0 ± 8.3 |
| Fasting plasma glucose (mmol/l) | 8.9 ± 1.8 | 9.2 ± 2.4 |
| HbA1c (%) | 8.6 ± 1.4 | 8.4 ± 1.5 |
| Fasting plasma C-peptide (ng/ml) | 0.10 ± 0.29 | 0.09 ± 0.25 |
| Daily insulin dose (IU/kg) | 0.58 ± 0.16 | 0.62 ± 0.19 |
| Autoimmune diseases (%) | 11.8 | 5.5 |
| Hypertension (%) | 41.2 | 30.6 |
| . | anti-CD38+ . | anti-CD38− . |
|---|---|---|
| n | 18 | 76 |
| Sex (%) | ||
| Male | 47.1 | 56.2 |
| Female | 52.9 | 43.8 |
| Age (years) | 36.8 ± 13.9 | 37.3 ± 11.2 |
| BMI (kg/m2) | 23.5 ± 3.4 | 24.4 ± 3.3 |
| Diabetes duration (years) | 19.9 ± 10.9 | 20.0 ± 8.3 |
| Fasting plasma glucose (mmol/l) | 8.9 ± 1.8 | 9.2 ± 2.4 |
| HbA1c (%) | 8.6 ± 1.4 | 8.4 ± 1.5 |
| Fasting plasma C-peptide (ng/ml) | 0.10 ± 0.29 | 0.09 ± 0.25 |
| Daily insulin dose (IU/kg) | 0.58 ± 0.16 | 0.62 ± 0.19 |
| Autoimmune diseases (%) | 11.8 | 5.5 |
| Hypertension (%) | 41.2 | 30.6 |
Data are means ± SD unless otherwise indicated. P = NS.